Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: In vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis

Journal of Biomedical Materials Research

Volumn 46, Issue 4, 1999, Pages 494-503

  Yagmurlu, M Firat ^a   Korkusuz, Feza ^b   Gürsel, Ihsan ^b   Korkusuz, Petek ^c   Örs, Ülken ^c   Hasirci, Vasif ^b,d  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Northeastern University   (United States)

Author keywords

Biodegradable polymers; Controlled release; Local antibiotic delivery; Osteomyelitis; Polyhydroxybutyrate co hydroxyvalerate

Indexed keywords

POLY(3 HYDROXYBUTYRIC ACID); SULPERAZON; VALERIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BIOCOMPATIBILITY; CHRONIC OSTEOMYELITIS; DRUG DELIVERY SYSTEM; EXPERIMENTAL INFECTION; IMPLANT; NONHUMAN; REMISSION; STAPHYLOCOCCUS AUREUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CEFOPERAZONE; DRUG CARRIERS; DRUG IMPLANTS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG THERAPY, COMBINATION; OSTEOMYELITIS; POLYESTERS; RABBITS; STAPHYLOCOCCAL INFECTIONS; SULBACTAM; TIBIA;

EID: 0033567843     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19990915)46:4<494::AID-JBM7>3.0.CO;2-E     Document Type: Article

References (57)

1. Praemer A, Furner S, Rice DP. Musculoskeletal conditions in the United States. Parkridge, Illinois: American Academy of Orthopaedic Surgeons; 1992.
2. Petty W, Spanier S, Shuster JJ, Silverthorne C. The influence of skeletal implants on incidence of infection. J Bone Joint Surg 1985;67-A:1236-1244.
3. Spanghel MJ, Younger ASE, Masri BA, Duncan CP. Diagnosis of infection following total hip arthroplasty. J Bone Joint Surg 1997;79-A:1578-1588.
4. Cierny G. Chronic osteomyelitis. Results of treatment. In: International course lectures, Vol. 39. Partridge, Illinois: American Academy of Orthopaedic Surgeons; 1990. p 495-514.
5. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med 1997;336: 999-1007.
6. Gristina AG, Costerton JW, Webb LX. Microbial adhesion, biofilms and the pathophysiology of osteomyelitis. In: D'Ambrosia RD, Marier RL, editors. Orthopaedic infections. New Jersey: Slack Inc.; 1989. p 49-70.
7. Bucholz HW, Heinert K, Foerster GW. Infected prostheses: The role of antibiotic cement. In: D'Ambrosia RD, Marier RL, editors. Orthopaedic infections. New Jersey: Slack Inc.; 1989. p 477-488,
8. Perry CR, Pearson RL. Local antibiotic delivery in the treatment of bone and joint infections. Clin Orthop Rel Res 1991; 263:215-226.
9. Wahling H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads. J Bone Joint Surg 1978;60-B:270-275.
10. Vecsei V, Barquet A. Treatment of chronic osteomyelitis by necrotomy and gentamicin-PMMA beads. Clin Orthop Rel Res 1981;159:201-207.
11. Bayston R, Milner RDG. The sustained release of antimicrobial drugs from bone cement. J Bone Joint Surg 1982;64-B:460-464.
12. Murray WR. Use of antibiotic-containing bone cement. Clin Orthop Rel Res 1984;190:89-95.
13. Bucholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: Current concepts. Clin Orthop Rel Res 1984;190:96-108.
14. Majid SA, Lindberg LT, Gunterberg B, Siddiki MS. Gentamicin-PMMA beads in the treatment of chronic osteomyelitis. Acta Orthop Scand 1985;56:265-268.
15. Blaha JD, Calhoun JH, Nelson CL, Henry SL, Selgison D, Esterhai JL Jr, Heppenstall RB, Mader J, Evans RP, Wilkins J, Patzakis MJ, Spiegel P. Comparison of the clinical efficacy and tolerance of gentamicin-PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Rel Res 1993;295:8-12.
16. Baker AS, Greenham LW. Release of gentamicin from acrylic bone cement. J Bone Joint Surg 1988;70-A:1551-1557.
17. Vaudaux PE, Zulian G, Huggler E, Waldvogel FA. Attachment of staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection. Infect Immun 1985;50:472-477.
18. Calhoun J, Daum W, Mader JT, Koulisis C, Evans EB. Failure of bipolar hip arthroplasty secondary to retained antibioticimpregnated polymethylmethacrylate beads. J Bone Joint Surg 1988;70-A:246-248.
19. Fiddian NJ, Sudlow RA, Browett JP. Ruptured femoral vein. A complication of the use of gentamicin beads in an infected excision arthroplasty of the hip. J Bone Joint Surg 1984;66-B: 493-494.
20. rd G. Evaluation of biodegradable ampicillin anhy-drate microcapsules for local treatment of experimental staphylococcal osteomyelitis. Clin Orthop Rel Res 1991;267:237-244.
21. rd G, Fallon MT, McNeill JF, Siderys GS. Evaluation of biodegradable cefalozin sodium microspheres for the prevention of infection in rabbits with experimental open tibial fractures stabilized with internal fixation. J Orthop Res 1993;11:404-411.
22. rd G, Zorn K, McNeill JF, Fallon MT. Delayed local treatment of rabbit tibial fractures with biodegradable cefalozin microspheres. Clin Orthop Rel Res 1997;336:278-285.
23. Wei G, Kotoura Y, Oka M, Yamamuro T, Wada R, Hyon S, Ikada Y. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. J Bone Joint Surg 1991;73-B:246-252.
24. Sampath SS, Garvin K, Robinson DH. Preparation and characterisation of biodegradable poly(L-lactic acid) gentamicin delivery systems. Int J Pharm 1992;78:165-174.
25. Teupe C, Meffert R, Winckler S, Ritzerfeld W, Törmälä P, Brug E. Ciprofoxacin-impregnated poly-L-lactic acid drug carrier. Arch Orthop Traumatol Surg 1992;112:33-35.
26. Garvin KL, Miyano JA, Robinson D, Giger D, Novak J, Radio S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. J Bone Joint Surg 1994;76-A:1500-1506.
27. Otsuka M, Matsuda Y, Yu D, Wong J, Fox JL, Higuchi WI. A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement. Chem Pharm Bull 1990;38:3500-3502.
28. Yamamura K, Iwata H, Yotsuyanagi T. Synthesis of antibioticloaded hydroxyapatite beads and in vitro drug release testing. J Biomed Mater Res 1992;26:1053-1064.
29. Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg 1992;74-B:600-604.
30. Korkusuz F, Uchida A, Inoue K, Shinto Y, Araki N, Ono K. Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. J Bone Joint Surg 1993;75-B:111-114.
31. Cornell CN, Tyndall D, Waller S, Lane JM, Brause BD. Treatment of experimental osteomyelitis with antibioticimpregnated bone graft substitute. J Orthop Res 1993;11:619-626.
32. Itokazu M, Matsunaga T, Kumazawa S, Wenyi Y. A novel drug delivery system for osteomyelitis using porous hydroxyapatite blocks loaded by centrifugation. J Appl Biomater 1995;6:167-169.
33. Radin S, Campbell JT, Ducheyne P, Cuckler JM. Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 1997;18:777-782.
34. Takano I, Ishi Y. Experimental study of apatite cement containing antibiotics. J Orthop Sci 1997;2:98-105.
35. Ikada Y, Hyon SH, Jamshidi K, Higashi S, Yamamuro T, Katutani Y, Kitsugi T. Release of antibiotic from composites of hydroxyapatite and poly (lactic acid). J Controlled Release 1985; 2:179-186.
36. Tegander A, Engebretsen L, Bergh K, Eide E, Holen KJ, Iversen OJ. Activation of the complement system and adverse effects of biodegradable pins of polylactic acid (Biofix) in osteochondritis dissecans. Acta Orthop Scand 1994;65:472-475.
37. Robinson BP, Holinger JO, Szachhowicz EH, Brekke J. Calvarial bone repair with porous D, L-polylactide. Otolaryngol Head Neck Surg 1995;112:707-713.
38. Tams J, Rozema FR, Bos RR, Roodenburg JL, Nikkels PG, Vermey A. Poly(L-lactide) bone plates and screws for internal fixation of mandibular swing-osteotomies. Int J Oral Maxillofac Surg 1996;25:20-24.
39. Gürsel I. Use of microbial polyhydroxyalkanoates in the construction of biomedical drug release systems [PhD thesis]. Ankara, Turkey: Middle East Technical University; 1995.
40. Yagmurlu M F, Sarsu A, Korkusuz P, Ors U, Korkusuz F, Gürsel I, Hasirci V. Treatment of experimental osteomyelitis via antibiotic-loaded polyhydroxybutyrate-co-hydroxyvalerate depot system, In: Proceedings of the XV National Orthopaedic and Traumatology Congress; 1997 Sept 13-14; Istanbul, Turkey. 1997. p 898-901.
41. Lee SY. Plastic bacteria? Progress and prospects for polyhydroxyalkanoate production in bacteria. Trends Biotechnol 1996;14:431-438.
42. Pouton CW, Akhtar S. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv Drug Del Rev 1996; 18:133-162.
43. Gürsel I, Hasirci V. Microcapsules of PHB and PHBV: Morphology and release characteristics. J. Microencapsulation 1995;12:185-193.
44. Korkusuz F, Uchida A, Shinto Y, Inoue K, Ono K. Biomaterialcentered chronic osteomyelitis. An experimental model at the cortical bones of rats. Turkish J Med Res 1992;10:286-292.
45. Dahners LE, Funderburk CH. Gentamicin-loaded plaster of Paris as a treatment of experimental osteomyelitis in rabbits. Clin Orthop Rel Res 1987;219:278-282.
46. Smeltzer MS, Thomas JR, Hickmon SG, Skinner RA, Nelson CL, Griffith D, Parr TR, Evans RP. Characterization of rabbit model of staphylococcal osteomyelitis. J Orthop Res 1997;15: 414-421.
47. Gerhart TN, Roux RD, Hanff PA, Horowitz GL, Renshaw AA, Hayes WC. Antibiotic-loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats. J Orthop Res 1993;11:250-255.
48. Knowles JC, Hastings GW, Ohta H, Niwa S, Boeree N. Development of a degradable composite for orthopaedic use: In vivo biomechanical and histological evaluation of two bioactive degradable composites based on the polyhydroxybutyrate polymer. Biomaterials 1992;13:491-496.
49. Hollinger JO, Battistone GC. Biodegradable bone repair materials. Clin Orthop Rel Res 1986;207:290-305.
50. Wei G, Kotoura Y, Oka M, Yamamuro T, Wada R, Hyon S, Ikada Y. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. J Bone Joint Surg 1991;73-B:246-252.
51. Paivarinta U, Böstman O, Majola A, Toivonen T, Törmala P, Rokkanen P. Intraosseous cellular response to biodegradable fracture fixation screws made of polyglycolide or polylactide. Acta Orthop Traumatol Surg 1993;112:71-74.
52. Böstman O, Hirvensalo E, Makinen J, Rokkanen P. Foreignbody reactions to fracture fixation implants of biodegradable synthetic polymers. J Bone Joint Surg 1990;72-B:592-596.
53. Santavirta S, Konttinen YT, Saito T, Gronblad M, Partio E, Kemppinen P, Rokkanen P. Immune response to polyglycolic acid implants. J Bone Joint Surg 1990;72-B:597-600.
54. Barfod G, Svendsen RN. Synovitis of the knee after intraarticular fracture fixation with Biofix. Acta Orthop Scand 1992;63: 680-681.
55. Friden T, Rydholm U. Severe aseptic synovitis of the knee after biodegradable internal fixation. Acta Orthop Scand 1992;62:94-97.
56. Böstman O, Paivarinta U, Partio E, Vasenius J, Manninen M, Rokkanen P. Degradation and tissue replacement of an absorbable polyglycolide screw in the fixation of rabbit femoral osteotomies. J Bone Joint Surg 1992;74-A:1021-1031.
57. Schmidt C, Wenz R, Nies B, Moll F. Antibiotic in vivo/in vitro release, histocompatibility and biodegradation of gentamicin implants based on lactic acid polymers and copolymers. J Controlled Release 1995;37:83-94.